Issue 1806: March 26, 2025

Laminated booklets of the 2025 U.S. child and adolescent immunization schedule and the 2025 U.S. adult immunization schedule are available now in the Immunize.org shop.

The schedules are available online as PDFs from CDC at no cost. Immunize.org’s laminated booklets are ideal for use in any busy healthcare setting where vaccines are given. Features include:

• Durability: Their tough coating can be wiped down, and they can stand up to a year's worth of use.
• Format: Each schedule is produced in an 8.5” X 11” booklet format; with color coding for easy reading, our laminated schedules replicate the original CDC formatting, including all tables and notes. The adult schedule is 16 pages and the child and adolescent schedule is 20 pages.
• Easy access to CDC updates: The CDC online schedule includes an addendum page that will display ACIP’s new recommendations as CDC adopts them during 2025. Each Immunize.org laminated schedule addendum page includes QR codes you can scan to view or print the online addendum page as it is revised.
• Bonus content: Both schedules include a bonus page with Immunize.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients.

          


Pricing:
 

Child and Adolescent Booklets	Adult Booklets
1 copy: $10.50	1 copy: $10.00
2–4 copies: $10.00 each	2–4 copies: $9.50 each
5–19 copies: $9.00 each	5–19 copies: $8.50 each
20–99 copies: $8.00 each	20–99 copies: $7.50 each
100–499 copies: $6.50 each	100–499 copies: $6.00 each
500–999 copies: $5.50 each	500–999 copies: $5.00 each
1,000–1,999 copies: $4.50 each	1,000–1,999 copies: $4.00 each
2,000+ copies: $3.75 each	2,000+ copies: $3.25 each

Visit the Shop Immunize.org: Laminated Schedules web page to view images and order today!

For additional information, call 651-647-9009 or email admininfo@immunize.org.

Related Links

• Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) web page
• Immunize.org: Laminated Adult Immunization Schedules (19 and older) web page
• Immunize.org: Shop Immunize.org main page 

Confident healthcare provider recommendations for influenza vaccine are powerfully persuasive. This influenza season has been a tough one and it is not over yet. To help you maximize patient protection, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense website.



This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:

• Influenza in Adults 65+: The Facts
• Influenza Vaccination: Questions Patients Aged 65 and Older Frequently Ask Their HCP
• The Importance of Preventing Influenza and COVID-19

Older adults are at increased risk of severe influenza, COVID-19, and RSV illness, including hospitalization and death, especially if they are not up to date on these vaccinations. A clinician recommendation is the most important reason why a patient will get vaccinated.

Check out the updated 65+ Flu Defense website to assist your ongoing efforts in protecting this vulnerable population.

---

Immunize.org’s elegantly designed “Vaccines Save Lives” pins are meaningful gifts for people who care about vaccination. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75". The pin features a stick-through-post with the back covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.


Wear these pins on clothing, uniforms, and white coats to show that you value vaccines.

    

Click here for "Vaccines Save Lives" pin pricing and ordering information.

---

In the March 14 issue, Pediatrics published COVID-19 Vaccination During Pregnancy and Major Structural Birth Defects. Portions of the results and conclusions sections appear below.

Among 78,052 pregnancies, we identified 1248 major structural birth defects . . . 160.6 per 10,000 live births . . . among unvaccinated people and . . . 156.4 per 10 000 live births . . . among vaccinated people . . . No differences in the prevalence of major structural birth defects were observed given COVID-19 vaccination . . . Findings were unchanged by insurance provider, SARS-CoV-2 infection during pregnancy, and concomitant of other maternal vaccines. No differences in the prevalence of birth defects were observed among vaccinated people by brand . . .

COVID-19 vaccination during early pregnancy is not associated with an increased prevalence of major structural birth defects in infants. These results support the safety of COVID-19 vaccination in early pregnancy.



A video abstract is available.

---

On March 18, CDC issued a Health Alert Network (HAN) Health Update: Ongoing Risk of Dengue Virus Infections and Updated Testing Recommendations in the United States. CDC issued this HAN to provide additional information on dengue virus transmission in the United States, use of a specific assay when dengue is the most likely diagnosis, and new resources for investigating and responding to dengue cases in non-endemic areas of the United States.



Related Links

• CDC: Global Dengue main page 
• Immunize.org: Vaccines A–Z: Dengue main page

---

---

To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, April 9 at 4:00 p.m. (ET) or Thursday, April 10 at 12:00 p.m. (ET). The same content will be covered in both sessions.
 
We will open each 45-minute session with a short, live demonstration on navigating the following site content: publication archives, vaccine timeline, and information about our organization. You can submit questions when you register or live on Zoom during the session.



Register today for Immunize.org Website Office Hours (content is the same for both):

• Wednesday, April 9 at 4:00 p.m. (ET)
• Thursday, April 10 at 12:00 p.m. (ET)

The archive of previous Website Office Hours content is posted at Immunize.org’s Webinars & Videos page. Website sections covered in the archived webinars include Ask the Experts; Clinical Resources; Vaccine Information Statements (VISs); Images, Webinars, Videos, & Social Media; Official Guidance; Travel Vaccines, Vaccine Confidence & Addressing Concerns; and Vaccines A–Z.

Mark your calendar for future Immunize.org Website Office Hours.

---

After postponing the regularly scheduled February ACIP meeting, CDC will now convene the ACIP on April 15–16. The ACIP will discuss vaccines targeting chikungunya, COVID-19, cytomegalovirus, HPV, influenza, Lyme disease, meningococcal disease, mpox, pneumococcal disease, and RSV. An update on the multistate measles outbreak will be provided.



No registration is required to watch webcasts of live ACIP meetings or listen via telephone. Opportunities for written or oral public comment are described on the website.

View meeting information.

Related Links

• CDC: ACIP main page for access to webcast, agendas
• CDC: ACIP: Meeting Information for presentation slides, content from previous meetings, and information about future meetings

---

For more upcoming events, visit our Calendar of Events.